Steady-state pharmacokinetics and bioavailability of immediate-release and extended-release formulations of lamotrigine in elderly epilepsy patients: Use of stable isotope methodology

Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release

(2016) Mary-Ann Werz   Therapeutics and Clinical Risk Management

Safety of an intravenous formulation of lamotrigine

(2014) Jeannine M. Conway et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Intravenous topiramate: Comparison of pharmacokinetics and safety with the oral formulation in healthy volunteers

(2013) Anne M. Clark et al.   EPILEPSIA

Steady-State Carbamazepine Pharmacokinetics Following Oral and Stable-Labeled Intravenous Administration in Epilepsy Patients: Effects of Race and Sex

(2012) S E Marino et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Extended-release antiepileptic drugs: A comparison of pharmacokinetic parameters relative to original immediate-release formulations

(2012) Ilo E. Leppik et al.   EPILEPSIA

Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics

(2012) B. B. Brzaković et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

The effect of age and comedication on lamotrigine clearance, tolerability, and efficacy

(2011) Hiba Arif et al.   EPILEPSIA

Variation in glucuronidation of lamotrigine in human liver microsomes

(2009) U. A. Argikar et al.   XENOBIOTICA

Population Pharmacokinetics of Lamotrigine in Elderly Patients

(2008) Baralee Punyawudho et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy

(2008) J. E. Ahn et al.   NEUROLOGY

Steady-state Pharmacokinetics of Lamotrigine when Converting from a Twice-daily Immediate-release to a Once-daily Extended-release Formulation in Subjects with Epilepsy (The COMPASS Study)

(2007) Debra J Tompson et al.   EPILEPSIA